Seaport Therapeutics, Inc. Common Stock

SPTX

SPTXSeaport Therapeutics, Inc. Common Stock US flag

NASDAQ Global Market

21.00

USD

+0.45

- -

1.12BMarket Cap

Income Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -
+ Sales & Services Revenue	- -	- -
- Cost of Revenue	- -	- -
+ Cost of Goods & Services	- -	- -
Gross Profit	- -	- -
+ Other Operating Income	- -	- -
- Operating Expenses	52	87
+ Selling, General & Admin	27	21
+ Research & Development	25	66
+ Other Operating Expense	- -	- -
Operating Income (Loss)	-52	-87
- Non-Operating (Income) Loss	-6	-13
+ Interest Expense, Net	-6	-11
+ Interest Expense	- -	- -
- Interest Income	6	11
+ Other Non-Op (Income) Loss	- -	-2
Pretax Income	-47	-74
- Income Tax Expense (Benefit)	- -	1
- (Income) Loss from Affiliates	- -	- -
Income (Loss) from Cont Ops	-47	-75
- Net Extraordinary Losses (Gains)	- -	- -
+ Discontinued Operations	- -	- -
+ Extraord. & Accounting Changes	- -	- -
Income (Loss) Incl. MI	-47	-75
- Minority Interest	- -	- -
Net Income, GAAP	-47	-75
- Preferred Dividends	- -	- -
- Other Adjustments	- -	- -
Net Income Avail to Common, GAAP	-47	-75
EBIT	-52	-87
EBITDA	-52	-86
EBITDA Margin (%)	- -	- -
EBITA	-52	-87
Gross Margin (%)	- -	- -
Operating Margin (%)	- -	- -
Profit Margin (%)	- -	- -
Sales per Employee	- -	- -
Dividend per Share	- -	- -
Depreciation Expense	- -	1
Basic Weighted Avg Shares	39	39
Basic EPS, GAAP	-1.21	-1.94
Basic EPS from Cont Ops	-1.21	-1.94
Diluted Weighted Avg Shares	39	39
Diluted EPS, GAAP	-1.21	-1.94
Diluted EPS from Cont Ops	-1.21	-1.94

Balance Sheet (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Current Assets	310	223
+ Cash, Cash Equivalents & STI	309	216
+ Cash & Cash Equivalents	309	46
+ ST Investments	- -	170
+ Accounts & Notes Receiv	- -	3
+ Accounts Receivable, Net	- -	- -
+ Notes Receivable, Net	- -	- -
+ Loans Receivable, Net	- -	- -
+ Other Receivable, Net	- -	3
+ Inventories	- -	- -
+ Raw Materials	- -	- -
+ Work In Process	- -	- -
+ Finished Goods	- -	- -
+ Inventory Adjustments	- -	- -
+ Other Inventory	- -	- -
+ Other ST Assets	1	4
+ Misc ST Assets	- -	- -
+ Prepaid Expenses	- -	- -
+ ST Derivative & Hedging Assets	- -	- -
+ ST Assets Held-for-Sale	- -	- -
+ ST Deferred Tax Assets	- -	- -
Total Noncurrent Assets	6	26
+ Property, Plant & Equip, Net	5	5
+ Property, Plant & Equip	6	6
- Accumulated Depreciation	1	1
+ LT Investments & Receivables	- -	18
+ LT Investments	- -	18
+ LT Receivables	- -	- -
+ Other LT Assets	- -	3
+ Total Intangible Assets	- -	- -
+ Goodwill	- -	- -
+ Other Intangible Assets	- -	- -
+ LT Deferred Tax Assets	- -	- -
+ LT Derivative & Hedging Assets	- -	- -
+ Misc LT Assets	- -	3
Total Assets	316	249
+ Payables & Accruals	7	6
+ Accounts Payable	5	2
+ Accrued Taxes	- -	- -
+ Interest & Dividends Payable	- -	- -
+ Other Payables & Accruals	3	4
+ ST Debt	1	2
+ ST Borrowings	- -	- -
+ ST Finance Leases	1	2
+ Other ST Liabilities	3	5
+ Deferred Revenue	- -	- -
+ Derivatives & Hedging	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Misc ST Liabilities	3	5
Total Current Liabilities	11	13
+ LT Debt	4	3
+ LT Borrowings	- -	- -
+ LT Finance Leases	4	3
+ Other LT Liabilities	325	325
+ Accrued Liabilities	- -	- -
+ Pension Liabilities	- -	- -
+ Deferred Revenue	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Derivatives & Hedging	- -	- -
+ Misc LT Liabilities	325	325
Total Noncurrent Liabilities	329	329
Total Liabilities	341	342
+ Preferred Equity and Hybrid Capital	- -	- -
+ Share Capital & APIC	14	21
+ Common Stock	- -	- -
+ Additional Paid in Capital	14	21
- Treasury Stock	- -	- -
+ Retained Earnings	-39	-114
+ Other Equity	- -	- -
Equity Before Minority Interest	-25	-93
+ Minority/Non Controlling Interest	- -	- -
Total Equity	-25	-93
Total Liabilities & Equity	316	249
Shares Outstanding	53	53
Number of Employees	- -	- -
Capital Leases - Total	5	5
Net Debt	-309	-46
Net Debt to Equity	1,243.91	49.75
Tangible Common Equity Ratio	-7.87	-37.17
Current Ratio	27.82	17.46
Cash Conversion Cycle	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

+ Net Income	-47	-75
+ Depreciation & Amortization	- -	1
+ Non-Cash Items	15	3
+ Stock-Based Compensation	15	7
+ Deferred Income Taxes	- -	- -
+ Asset Impairment Charge	- -	- -
+ Other Non-Cash Adj	- -	-3
+ Chg in Non-Cash Work Cap	3	-8
+ (Inc) Dec in Accts Receiv	- -	- -
+ (Inc) Dec in Inventories	- -	- -
+ (Inc) Dec in Prepaid Assets	-1	-6
+ Inc (Dec) in Accts Payable	3	1
+ Inc (Dec) in Other	- -	-3
+ Net Cash From Disc Ops	- -	- -
Cash from Operating Activities	-30	-78
+ Change in Fixed & Intang	- -	- -
+ Disp in Fixed & Intang	- -	- -
+ Disp of Fixed Prod Assets	- -	- -
+ Disp of Intangible Assets	- -	- -
+ Acq of Fixed & Intang	- -	- -
+ Acq of Fixed Prod Assets	- -	- -
+ Acq of Intangible Assets	- -	- -
+ Cash (Repurchase) of Equity	- -	- -
+ Increase in Capital Stock	- -	- -
+ Decrease in Capital Stock	- -	- -
+ Net Change in LT Investment	- -	-184
+ Dec in LT Investment	- -	212
+ Inc in LT Investment	- -	-396
+ Net Cash From Acq & Div	- -	- -
+ Cash from Divestitures	- -	- -
+ Cash for Acq of Subs	- -	- -
+ Cash for JVs	- -	- -
+ Other Investing Activities	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Investing Activities	- -	-184
+ Dividends Paid	- -	- -
+ Net Cash From Debt	- -	- -
+ Cash From Debt	- -	- -
+ Repayments of Debt	- -	- -
+ Other Financing Activities	339	-1
+ Net Cash From Disc Ops	- -	- -
Cash from Financing Activities	339	-1
Effect of Foreign Exchange Rates	- -	- -
Net Changes in Cash	310	-263
EBITDA	-52	-86
EBITDA Margin (%)	- -	- -
Free Cash Flow	-30	-78
Net Cash Paid for Acquisitions	- -	- -
Free Cash Flow to Firm	- -	- -
Free Cash Flow to Equity	- -	-78
Free Cash Flow per Basic Share	-0.77	-2.03
Price/Free Cash Flow	- -	- -
Cash Flow to Net Income	0.63	1.04
Capital Expenditures	- -	- -